🇮🇳IN
Sign In
SA

SAILIFE

NSE

Sai Life Sciences Limited

₹1,558.20

+10.90(+0.70%)

Group Companies

Foreign Flows

sector level — not this stock
Healthcare sector+₹3 Crnet foreign buying
2026-09-16 to 2026-09-end

This is the flow into the whole Healthcare sector, not into SAILIFE. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.

Supply Chain

suppliers and customers in the graph

Relationship Network

directors, institutions, group entities

Macro Sensitivity

rates, currency, commodities

Revenue by Segment

Business Group

Geographic Exposure

revenue, imports, currency

Scenario analysis

stated assumptions, shown workings

SAILIFE exposure summary

Sai Life Sciences Limited reports a single business segment, Contract Research, Development and Manufacturing (CRDMO). Sai Life Sciences Limited is a constituent of 6 indices, with its largest weights in NIFTY Pharma (2.05%), NIFTY Smallcap 100 (1.55%), S&P BSE 500 (0.10%). 15 exchange-traded funds hold the stock.

Index memberships6
ETFs holding15

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer